Powered by

Aurinia Establishes At-the-Market Facility

Sep 13, 2019 - Business Wire

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX:AUP) ("Aurinia" or the "Company"), a late- stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced that it has entered into an Open Market Sales Agreement with Jefferies LLC ("Jefferies") pursuant to which the Company may from time to time sell, through at-the-market ("ATM") offerings with Jefferies acting as sales agent, such common shares as would have an aggregate offer price of up to U...